Clinical Important Dysregulation of Long Non-coding RNA CCHE1 and HULC in Carcinogenesis of Cervical Cancer

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2019 Aug 1

PMID 31364021

Citations 9

Authors

Neda Naghashi

Saeid Ghorbian

Affiliations

Soon will be listed here.

Abstract

Genetic analysis has revealed that the lncRNAs acted in the critical pathways including cell growth, cell differentiation, and tumorigenesis. The purpose of the present survey was to evaluate the lncRNA-CCHE1 and lncRNA-HULC expression variations in subjects with cervical malignancy. In our case-control analysis planned on 100 formalin-fixed paraffin-embedded (FFPE) samples comprising 50 paraffin blocks of cervical cancerous and 50 paraffin blocks of non-tumors samples. We have calculated the lncRNA-CCHE1 and lncRNA-HULC gene expression alterations using a quantitative RT-PCR approach. Our results declared that the lncRNA-CCHE1 expression was considerably raised in tumorous matched to the non-tumorous samples (P = 0.001). Moreover, the lncRNA-HULC expression was not considerably modified between tumorous samples matched to the non-tumorous samples (P = 0.060). In extension, lncRNA-CCHE1 expression variation was correlated with the histological type (P = 0.001), tumor size (P = 0.001) and FIGO stage (P = 0.001). Our data advised that the lncRNA-CCHE1 gene may influence cervical malignancy progression, held as a prognostic marker and useful curative target. However, the character of lncRNA-HULC in carcinogenesis of cervical malignancy requires further analyses.

Citing Articles

New sights on long non-coding RNAs in glioblastoma: A review of molecular mechanism.

Bagheri-Mohammadi S, Karamivandishi A, Mahdavi S, Siahposht-Khachaki A Heliyon. 2024; 10(21):e39744.

PMID: 39553554 PMC: 11564028. DOI: 10.1016/j.heliyon.2024.e39744.

SOX21-AS1 Augmented Cervical Cancer Growth by Triggering FZD3 to Activate the Wnt/β-Catenin Signaling Pathway.

Zhi Y, Du P, Li Y, Liu H, Jiang T, Zhao X Biochem Genet. 2024; 63(1):761-774.

PMID: 38512584 DOI: 10.1007/s10528-024-10770-0.

Expression Level of lncRNA CYTOR in Iranian Cervical Cancer Patients.

Rajabi A, Dastmalchi N, Shokri N, Tayefeh-Gholami S, Yaghoubi S, Safaralizadeh R Rep Biochem Mol Biol. 2023; 12(1):120-126.

PMID: 37724154 PMC: 10505465. DOI: 10.52547/rbmb.12.1.120.

The IncRNA SCIRT Promotes the Proliferative, Migratory, and Invasive Properties of Cervical Cancer Cells by Upregulating MMP-2/-9.

Guan C, Wang B, Dong Q J Oncol. 2022; 2022:3448224.

PMID: 35979035 PMC: 9377974. DOI: 10.1155/2022/3448224.

Serum Levels of lncRNA CCHE1 and TCF21 in Patients with Coronary Artery Disease and Their Clinical Significances.

Liu M, Zhang Y, Cao X, Wang X Dis Markers. 2021; 2021:8526144.

PMID: 34970358 PMC: 8714324. DOI: 10.1155/2021/8526144.

References

Dasari S, Wudayagiri R, Valluru L . Cervical cancer: Biomarkers for diagnosis and treatment. Clin Chim Acta. 2015; 445:7-11. DOI: 10.1016/j.cca.2015.03.005. View

Aalijahan H, Ghorbian S . Long non-coding RNAs and cervical cancer. Exp Mol Pathol. 2018; 106:7-16. DOI: 10.1016/j.yexmp.2018.11.010. View

Chen Y, Wang C, Sun X, Wang C, Liu T, Wang D . Long non-coding RNA CCHE1 overexpression predicts a poor prognosis for cervical cancer. Eur Rev Med Pharmacol Sci. 2017; 21(3):479-483. View

Peng W, Fan H . Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway. Biomed Pharmacother. 2016; 83:450-455. DOI: 10.1016/j.biopha.2016.06.056. View

Panzitt K, Tschernatsch M, Guelly C, Moustafa T, Stradner M, Strohmaier H . Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 2007; 132(1):330-42. DOI: 10.1053/j.gastro.2006.08.026. View

DU Y, Kong G, You X, Zhang S, Zhang T, Gao Y . Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem. 2012; 287(31):26302-11. PMC: 3406714. DOI: 10.1074/jbc.M112.342113. View

Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y . CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010; 38(16):5366-83. PMC: 2938198. DOI: 10.1093/nar/gkq285. View

Jin C, Shi W, Wang F, Shen X, Qi J, Cong H . Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer. Oncotarget. 2016; 7(32):51763-51772. PMC: 5239513. DOI: 10.18632/oncotarget.10107. View

Wang Y, Zhang S, Li X, Wang Y . Expression of lncRNA HULC in cervical cancer and its correlation with tumor progression and patient survival. Eur Rev Med Pharmacol Sci. 2016; 20(19):3987-3991. View

10.

Tuo Y, Li X, Luo J . Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143. Eur Rev Med Pharmacol Sci. 2015; 19(18):3403-11. View

11.

Matouk I, Abbasi I, Hochberg A, Galun E, Dweik H, Akkawi M . Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroenterol Hepatol. 2009; 21(6):688-92. DOI: 10.1097/meg.0b013e328306a3a2. View

12.

Li S, Xu H, Yu Y, He J, Wang Z, Xu Y . LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway. Oncotarget. 2016; 7(27):42431-42446. PMC: 5173146. DOI: 10.18632/oncotarget.9883. View

13.

Xin X, Wu M, Meng Q, Wang C, Lu Y, Yang Y . Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a. Mol Cancer. 2018; 17(1):94. PMC: 5998602. DOI: 10.1186/s12943-018-0843-8. View

14.

Zhao Y, Guo Q, Chen J, Hu J, Wang S, Sun Y . Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Oncol Rep. 2013; 31(1):358-64. DOI: 10.3892/or.2013.2850. View

15.

Feng H, Wei B, Zhang Y . Long non-coding RNA HULC promotes proliferation, migration and invasion of pancreatic cancer cells by down-regulating microRNA-15a. Int J Biol Macromol. 2018; 126:891-898. DOI: 10.1016/j.ijbiomac.2018.12.238. View

16.

Xu G, Zhang Y, Li N, Zhang J, Xu R . LncRNA CCHE1 in the proliferation and apoptosis of gastric cancer cells. Eur Rev Med Pharmacol Sci. 2018; 22(9):2631-2637. DOI: 10.26355/eurrev_201805_14957. View

17.

Liao Y, Cheng S, Xiang J, Luo C . lncRNA CCHE1 increased proliferation, metastasis and invasion of non-small lung cancer cells and predicted poor survival in non-small lung cancer patients. Eur Rev Med Pharmacol Sci. 2018; 22(6):1686-1692. DOI: 10.26355/eurrev_201803_14581. View